Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP777290.RAXpFpaUyH7qt_q8kBQvndiiwn9PHhv5sw-XDGAcmhcA0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP777290.RAXpFpaUyH7qt_q8kBQvndiiwn9PHhv5sw-XDGAcmhcA0130_assertion type Assertion NP777290.RAXpFpaUyH7qt_q8kBQvndiiwn9PHhv5sw-XDGAcmhcA0130_head.
- NP777290.RAXpFpaUyH7qt_q8kBQvndiiwn9PHhv5sw-XDGAcmhcA0130_assertion wasGeneratedBy ECO_0000203 NP777290.RAXpFpaUyH7qt_q8kBQvndiiwn9PHhv5sw-XDGAcmhcA0130_provenance.
- NP777290.RAXpFpaUyH7qt_q8kBQvndiiwn9PHhv5sw-XDGAcmhcA0130_assertion wasDerivedFrom befree-20140225 NP777290.RAXpFpaUyH7qt_q8kBQvndiiwn9PHhv5sw-XDGAcmhcA0130_provenance.
- NP777290.RAXpFpaUyH7qt_q8kBQvndiiwn9PHhv5sw-XDGAcmhcA0130_assertion SIO_000772 23319569 NP777290.RAXpFpaUyH7qt_q8kBQvndiiwn9PHhv5sw-XDGAcmhcA0130_provenance.
- NP777290.RAXpFpaUyH7qt_q8kBQvndiiwn9PHhv5sw-XDGAcmhcA0130_assertion evidence source_evidence_literature NP777290.RAXpFpaUyH7qt_q8kBQvndiiwn9PHhv5sw-XDGAcmhcA0130_provenance.
- NP777290.RAXpFpaUyH7qt_q8kBQvndiiwn9PHhv5sw-XDGAcmhcA0130_assertion description "[Chemotherapy combined with Natalizumab prolonged survival of NOD/SCID recipients of primary ALL, suggesting adjuvant alpha4 inhibition as a novel strategy for pre-B ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP777290.RAXpFpaUyH7qt_q8kBQvndiiwn9PHhv5sw-XDGAcmhcA0130_provenance.